Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Stomatitis 1Neoplasms 1Keratosis, Actinic 1Carcinoma, Basal Cell 1

Interventions

3-ingenyl angelate 11Photochemotherapy 7Aminolevulinic Acid 7Imiquimod 6methyl 5-aminolevulinate 5Fluorouracil 5Gels 4Diclofenac 4Cryotherapy 3BF-200 ALA 3tirbanibulin 2Therapeutics 2Solutions 2green tea extract polyphenone E 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1Ointments 1LEO 43204 1Drugs, Generic 1Deoxyribonuclease (Pyrimidine Dimer) 1Cryosurgery 1Cosmetics 15-fluorouracil, salicylic acid drug combination 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Keratosis, Actinic × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT01966120 2023-07-28

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

Biofrontera Bioscience GmbH

Phase 3 Completed
87 enrolled 21 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡